EUVIMEDEUVIMED entdecken
Multizentrische Studie

Digoxin initiation after an acute heart failure episode and its association with post-discharge outcomes: an international multicenter analysis

Òscar Miró, Enrique Martín Mojarro iD, Gabrielle Huré, Pere Llorens, Víctor Gil, Aitor Alquézar-Arbé, Carlos Bibiano, Nayra Cabrera González, Marta Massó, Ivo Strebel, Begoña Espinosa, Silvia Mínguez Masó und 14 weitere

Internal and Emergency Medicine · 2025

DOI: 10.1007/s11739-024-03744-y ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Internal and Emergency Medicine, 2025. Verfasst von Òscar Miró und 25 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Catalonia, Spain. omiro@clinic.cat. Hauptthemen laut MEDLINE: Digoxin, Heart Failure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Digoxin is commonly used to treat acute heart failure (AHF), especially in patients with concurrent atrial fibrillation (AF). Nonetheless, there is little consensus about in which patients digoxin should be given, the proper time for digoxin initiation, and whether digoxin initiation is associated with improved outcomes. We investigated factors related to digoxin initiation after an episode of AHF and whether patients receiving digoxin presented better short-term outcomes. We analyzed digoxin-naïve AHF patients from a Spanish and Swiss database, who were dichotomized into cohorts based on their receipt of digoxin treatment at discharge. The relationship between digoxin initiation and 23 additional patient covariates, including chronic treatment, was investigated, as well as its association with 90-day combined adverse events (defined as all-cause death or AHF hospitalization). Of 13,105 patients (10,600/2505 from the Spanish/Swiss cohorts, respectively), the median (interquartile range) age was 83 (74.87) years, and 51% were women. Of these, 484 (3.7%) received digoxin at discharge, which was associated with AF, female sex, left ventricular ejection fraction (LVEF) < 50%, and coming from the Spanish cohort. Parameters inversely associated with receiving digoxin at discharge included some chronic treatments, diabetes mellitus (DM), and chronic kidney disease (CKD). Digoxin initiation was not association with 90-day adverse events, adjusted hazard ratio (aHR) = 0.939 (0.769-1.146), but there was an interaction for CKD, aHR = 1.390 (0.831-2.325) vs. 0.854 (0.682-1.183), p = 0.039, and for cohort pertinence, with higher risk in the Swiss cohort; aHR = 1.405 (0.827-2.386) vs. 0.862 (0.689-1.077), p = 0.046. Digoxin initiation after an AHF episode was more frequent in the Spanish cohort and was associated with certain patient characteristics (AF, female sex, reduced LVEF, no DM, no CKD), but had no effect on 90-day outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DigoxinHeart FailureHumansFemaleMaleAgedAged, 80 and overSpainPatient DischargeSwitzerlandCohort StudiesCardiotonic AgentsAtrial Fibrillation

Stichwörter der Autor:innen

Acute heart failureAtrial fibrillationHospitalizationMortalityOutcome

Substanzen

DigoxinCardiotonic Agents

Autor:innen und Institutionen

  • Emergency Department, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Catalonia, Spain. omiro@clinic.cat.
  • The GREAT Network, Rome, Italy. omiro@clinic.cat.
  • Emergency Department, Hospital Clínic, Villarroel 170, 08036, Barcelona, Catalonia, Spain. omiro@clinic.cat.
  • Emergency Department, Hospital Sant Pau I Santa Tecla, Tarragona, Catalonia, Spain.
  • The GREAT Network, Rome, Italy.
  • Cardiology Department, Cardiovascular Research Institute Basel (CRIB), University Hospital of Basel, University of Basel, Basel, Switzerland.

ORCID-Profile: Enrique Martín Mojarro

Zitieren

APA

Miró, Ò., Mojarro, E. M., Huré, G., Llorens, P., Gil, V., Alquézar-Arbé, A., Bibiano, C., González, N. C., Massó, M., Strebel, I., Espinosa, B., Masó, S. M., Wussler, D., Shrestha, S., Lopez-Ayala, P., Jacob, J., Millán, J., Andueza, J. A., Alonso, H., …, & investigators of the ICA-SEMES, CRIB research group (2025). Digoxin initiation after an acute heart failure episode and its association with post-discharge outcomes: an international multicenter analysis. Internal and Emergency Medicine. https://doi.org/10.1007/s11739-024-03744-y

Vancouver

Miró Ò, Mojarro EM, Huré G, Llorens P, Gil V, Alquézar-Arbé A, et al. Digoxin initiation after an acute heart failure episode and its association with post-discharge outcomes: an international multicenter analysis. Internal and Emergency Medicine. 2025. doi:10.1007/s11739-024-03744-y

BibTeX
@article{Mir2025,
  author = {Miró, Òscar and Mojarro, Enrique Martín and Huré, Gabrielle and Llorens, Pere and Gil, Víctor and Alquézar-Arbé, Aitor and Bibiano, Carlos and González, Nayra Cabrera and Massó, Marta and Strebel, Ivo and Espinosa, Begoña and Masó, Silvia Mínguez and Wussler, Desiree and Shrestha, Samyut and Lopez-Ayala, Pedro and Jacob, Javier and Millán, Javier and Andueza, Juan Antonio and Alonso, Héctor and Pàmies, Silvia Larrondo and Cerdà, Jaume Farré and Martínez, Celia Planco and Herrero, Pablo and Frank Peacock, W and Mueller, Christian and investigators of the ICA-SEMES, CRIB research group, investigators of the ICA-SEMES, CRIB research group},
  title = {Digoxin initiation after an acute heart failure episode and its association with post-discharge outcomes: an international multicenter analysis},
  journal = {Internal and Emergency Medicine},
  year = {2025},
  doi = {10.1007/s11739-024-03744-y}
}
Kostenlos starten →